What does an exoskeleton have to do with drug stabilization? Therapeutics, such as the COVID-19 vaccines Pfizer and Moderna, require refrigeration to maintain drug function. In an effort to bypass the expensive cold chain including vaccine distribution, storage, and usage, a team led by Dr. Gassensmith and Dr. Meloni researched the development of an affordable, scalable, and safe method for the enhancement of stabilizing lipid protein interactions. Watch this interactive talk show to learn more about their research and how an exoskeleton provides a shield against stressors.
Research 411 Talk Show: Stabilizing Delicate Drugs
by Alyssa Galganov